WeiQing Zhou

Founder at LifeMine Therapeutics, Inc.

Health Technology

Profile

WeiQing Zhou is the founder of Fog Pharmaceuticals, Inc. and holds the title of Chief Operating Officer.
Ms. Zhou is also the founder of LifeMine Therapeutics, Inc. and holds the title of Chief Operating Officer.

WeiQing Zhou active positions

Companies	Position	Start
LifeMine Therapeutics, Inc. LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA.	Founder	-
Fog Pharmaceuticals, Inc. Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA.	Founder	-

All active positions of WeiQing Zhou

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of WeiQing Zhou's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
LifeMine Therapeutics, Inc. LifeMine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LifeMine Therapeutics, Inc. develops drugs from fungi which aims to cure untreatable and significant chronic diseases. The company was founded by Gregory L. Verdine, WeiQing Zhou, Richard D. Klausner and Hingge Hsu and is headquartered in Cambridge, MA.	Health Technology
Fog Pharmaceuticals, Inc. Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA.	Health Technology